The economy and business portal Turkishtime published its ninth annual R&D 250 research. Based on 2021 data, Ali Raif became one of the “Highest R&D Spenders in Turkey” and placed fifth in all industries and fourth in the pharmaceutical industry in terms of the number of trademarks obtained in the R&D center. Ali Raif draws […]
- Login / Register
- 0 items - ₺0.00
- English
Our General Manager Nihal Arslan answered questions from WORKSHOP magazine. September 2021 Can you tell us briefly about your professional background? I graduated from Istanbul Technical University Faculty of Chemical Metallurgy Department of Chemical Engineering in 1984. I then completed the MBA program at Istanbul University Institute of Business Economics. I started my career in […]
August 2021 Fortune magazine continues to rank the largest companies in Turkey, just as it does in the United States, based on annual net turnover, exports, and profitability before tax, etc. Ali Raif İlaç continues its steady climb on the Fortune 500 List, which saw its 14th instalment this year. The Fortune 500 list includes […]
The Company Aims to Quadruple its Production Capacity Established in 1928, Ali Raif İlaç Sanayi has a deep-rooted history and an important place in the Turkish pharmaceutical industry with its 58 years of experience in the field. The company has now taken an important step in line with its growth targets and broke ground for […]
Ali Raif İlaç R&D Director Serdar Ünlü, Ph.D., answering the questions from Fortune magazine’s special issue on R&D, emphasized that the only way to shape the future of the Turkish pharmaceutical industry and have a presence in global markets is to engage in innovative R&D efforts and undertake the correct management of industrial rights that […]